STD Treatment
Mfg : Teva PharmaceuticalsMetronidazole 500mg
CDC-Recommended: First-line treatment for trichomoniasis and bacterial vaginosis.
Dual-Action Efficacy: Bactericidal against anaerobes and trichomonacidal.
Flexible Dosing: Single-dose option (2g) or 7-day course for trichomoniasis.
Proven Cure Rates: 90-95% effectiveness against trichomoniasis.
Comprehensive Treatment: Addresses both infection and associated symptoms like discharge.
Maximum Doses: 4
Per Dose $ 00.00
Total Price
Metronidazole is CDC-recommended as first-line treatment for trichomoniasis (single 2g dose or 7-day course) and bacterial vaginosis (7-day regimen). Clinical studies show 90-95% cure rates for trichomoniasis and 80-90% resolution of BV symptoms when taken as directed. Also used as part of combination therapy for pelvic inflammatory disease.
After entering microbial cells, metronidazole is reduced to active compounds that damage DNA and inhibit nucleic acid synthesis. This bactericidal and trichomonacidal action specifically targets anaerobic bacteria and protozoa without significantly affecting aerobic organisms or human cells.
Trichomoniasis: 2g single dose OR 500mg twice daily for 7 days
Bacterial Vaginosis: 500mg twice daily for 7 days
PID: 500mg twice daily for 14 days (with ceftriaxone)
Take with food to reduce stomach upset. Avoid alcohol during treatment and for 72 hours after last dose.
Common side effects: metallic taste (30%), nausea (10%), dark urine (harmless). Severe alcohol interaction causes disulfiram-like reaction (nausea/vomiting). Rare neurological side effects include peripheral neuropathy with long-term use. Contraindicated in first trimester pregnancy. Not for nursing mothers.
Highly effective against hard-to-treat anaerobic infections penetrates well into tissues and body fluids affordable generic option available in oral, topical, and IV formulations. Single-dose option improves adherence for trichomoniasis treatment.
